In another research, doxorubicin enhanced the transcription of SASP gene chemokine ligand 2 (CCL2) by activating NF-κB, thereby facilitating the growth and invasion of CRC cells both in vitro and in vivo. The gene discussed is CCL2; the disease is colorectal carcinoma.